JP2923263B2 - Feed composition for fish culture - Google Patents
Feed composition for fish cultureInfo
- Publication number
- JP2923263B2 JP2923263B2 JP9130875A JP13087597A JP2923263B2 JP 2923263 B2 JP2923263 B2 JP 2923263B2 JP 9130875 A JP9130875 A JP 9130875A JP 13087597 A JP13087597 A JP 13087597A JP 2923263 B2 JP2923263 B2 JP 2923263B2
- Authority
- JP
- Japan
- Prior art keywords
- curdlan
- fish
- feed
- feed composition
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000251468 Actinopterygii Species 0.000 title claims description 43
- 239000000203 mixture Substances 0.000 title claims description 34
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 46
- 239000001879 Curdlan Substances 0.000 claims description 44
- 229920002558 Curdlan Polymers 0.000 claims description 44
- 229940078035 curdlan Drugs 0.000 claims description 44
- 235000019316 curdlan Nutrition 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 7
- 235000019688 fish Nutrition 0.000 description 39
- 238000012360 testing method Methods 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- 241000252233 Cyprinus carpio Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 230000037396 body weight Effects 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- 238000009360 aquaculture Methods 0.000 description 7
- 244000144974 aquaculture Species 0.000 description 7
- 210000001539 phagocyte Anatomy 0.000 description 7
- 241000269908 Platichthys flesus Species 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000003308 immunostimulating effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000607471 Edwardsiella tarda Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960001438 immunostimulant agent Drugs 0.000 description 3
- 239000003022 immunostimulating agent Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 2
- 241000277288 Salmo trutta Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000009372 pisciculture Methods 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 241001303562 Centrolophus niger Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000701372 Iridovirus Species 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010029443 Nocardia Infections Diseases 0.000 description 1
- 206010029444 Nocardiosis Diseases 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 241000131739 Oncorhynchus masou rhodurus Species 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241000277277 Oncorhynchus nerka Species 0.000 description 1
- 241001280377 Oncorhynchus tshawytscha Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000861914 Plecoglossus altivelis Species 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000277263 Salmo Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- VEGOPIRPQIZFRD-UVHWXNHCSA-N [(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl] (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC(=O)\C=C\C1=CC=C(O)C=C1 VEGOPIRPQIZFRD-UVHWXNHCSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940072440 bovine lactoferrin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 235000019553 satiation Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、魚類養殖用飼料組
成物、さらに詳しくは、養殖魚類等の免疫活性を高める
ことによって養殖の場における生産性の向上を図るため
の魚類養殖用飼料組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a feed composition for aquaculture of fish, and more particularly, to a feed composition for aquaculture of fish for improving productivity in a farm by increasing the immunological activity of cultured fish and the like. About.
【0002】[0002]
【従来の技術】近年、水産の分野でも資源の枯渇が叫ば
れ、各種魚類の養殖が盛んに行われ、一定の成果を上げ
つつある。しかし、養殖水域の汚染、生産性を上げるた
めの過密養殖、種苗輸送の活発化に伴う病原菌の伝播な
どが原因で、魚に対する感染病が蔓延し、養殖の生産性
を著しく阻害している。この問題の解消のため、従来、
主として抗生物質などの薬品の投与が行われてきた。し
かし、食用に供する魚類に対する過剰な薬品の使用は、
その残留性や耐性菌の出現による効果の低下などの問題
を生じ、ここ数年、治療よりも、予防を目的とした各種
の免疫賦活剤が市場に供給されるようになった。これら
の一例としては、酵母、担子菌、海藻由来の多糖類、レ
バミゾール、ウシラクトフェリン、ビヒズス菌のペプチ
ドグリカンなどがある。2. Description of the Related Art In recent years, the depletion of resources has been called out in the field of fisheries, and aquaculture of various fishes has been actively carried out, and certain results have been obtained. However, infectious diseases on fish have become widespread due to contamination of aquaculture water areas, overcrowding for increasing productivity, and propagation of pathogenic bacteria due to increased seed and seedling transportation, thereby significantly impairing aquaculture productivity. To solve this problem,
Administration of drugs such as antibiotics has been mainly performed. However, the use of excess chemicals for edible fish,
Problems such as reduced persistence and the effect due to the emergence of resistant bacteria have arisen, and in recent years, various immunostimulants have been supplied to the market for the purpose of prevention rather than treatment. Examples of these include yeasts, basidiomycetes, polysaccharides derived from seaweed, levamisole, bovine lactoferrin, and peptidoglycan of Bifidobacterium.
【0003】[0003]
【発明が解決しようとする課題】本発明は、養殖の場で
病気に強い魚を飼育するために、相対的に安価で、添加
効果の優れた養殖魚類用の免疫賦活剤を新たに提供する
ことを目的とする。DISCLOSURE OF THE INVENTION The present invention provides a relatively inexpensive immunostimulant for cultured fish which is relatively inexpensive and has an excellent addition effect in order to raise disease-resistant fish in a farm. The purpose is to:
【0004】[0004]
【課題を解決するための手段】本発明者らは、魚類に対
する免疫賦活作用を有する化合物を探索する過程で、直
鎖のβ−1,3−グルカンであるカードランがその目的
に極めて有効であることを見いだし、本発明を完成する
に至った。すなわち、従来から、カードランがマウスに
対して抗腫瘍作用や補体活性化作用などの免疫賦活作用
を示すことが知られている。しかしながら、これは、あ
くまでも実験室で哺乳類に腹腔内投与がなされた場合で
あり、カードランが魚類の免疫系にどのような影響を及
ぼすか、さらには魚類の感染症に対して防御効果を示す
か否かについては全く情報はなかった。このような状況
に鑑み、本発明者らは、免疫賦活作用のあるカードラン
を水産養殖業界へ導入すべく、魚に対して経口で投与し
たところ、カードラン投与区は、対照区に比べて魚病菌
攻撃試験における生残率が著しく向上することがわかっ
た。また、カードランは食細胞の貧食活性を向上させる
こと、補体系を著しく活性化することなどの新たな知見
が得られた。In the process of searching for a compound having an immunostimulatory effect on fish, the present inventors found that curdlan, a linear β-1,3-glucan, was extremely effective for that purpose. They have found something and have completed the present invention. That is, it has been known that curdlan has immunostimulating effects such as an antitumor effect and a complement activating effect on mice. However, this is only the case when a mammal is given intraperitoneally in the laboratory, showing how curdlan affects the immune system of fish and also protects against fish infections. There was no information on whether or not. In view of such a situation, the present inventors administered orally to fish in order to introduce curdlan having an immunostimulating effect into the aquaculture industry. It was found that the survival rate in the fish disease challenge test was significantly improved. In addition, curdlan obtained new findings such as improving the phagocytic activity of phagocytes and remarkably activating the complement system.
【0005】本発明は、このような本発明者らの新たな
知見に基づくもので、カードランを含有してなることを
特徴とする養殖魚類用の飼料組成物を提供するものであ
る。本発明の飼料組成物は、飼料成分とカードランとを
配合してなるもので、通常、組成物全量に対して、0.
05〜5重量%の割合でカードランが配合され、また、
使用するカードランは水の存在下で、60℃以上に加熱
されたカードランであることが好ましい。[0005] The present invention is based on such new knowledge of the present inventors and provides a feed composition for cultured fish, which comprises curdlan. The feed composition of the present invention comprises a feed component and curdlan.
Curdlan is blended at a ratio of 0.5 to 5% by weight,
The curdlan used is preferably a curdlan heated to 60 ° C. or higher in the presence of water.
【0006】[0006]
【発明の実施の形態】本発明で使用するカードランは、
アルカリゲネス・フェカリスおよびアグロバクテリウム
属バクテリアの産生する直鎖のβ−1,3−グルカンで
ある。カードランは、原田ら(1966)によって発見
され、現在、食品添加物として主に食品用途に広く利用
されている。その構造は、グルコースがβ−1,3−結
合によって直鎖状につながったホモポリマーであり、β
−1,3−結合以外の結合およびグルコース以外の構成
糖は存在しないとされている。その特性は、水および各
種の有機溶媒に不溶、アルカリ、蟻酸溶液および尿素溶
液に可溶、そして60℃付近まで一旦加熱後さらに加熱
することにより加熱ゲルを形成(ハイセットゲル)し、
さらに、60℃付近まで加熱後、冷却すると冷却ゲルを
形成する(ローセットゲル)。また、フィルムを形成
し、さらに保湿効果などを示す。このように、カードラ
ンの大きな特性は、特に、温度および温度に対する履歴
によって著しくその物理化学的性質を異にすることであ
る。すなわち、カードランはその温度履歴によって分子
の構造がはなはだ異なる状態となる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The card run used in the present invention is as follows.
It is a linear β-1,3-glucan produced by Alcaligenes faecalis and Agrobacterium bacteria. Curdlan was discovered by Harada et al. (1966) and is currently widely used as a food additive, primarily in food applications. Its structure is a homopolymer in which glucose is connected linearly by β-1,3-linkage,
It is said that there is no bond other than the -1,3-bond and no constituent sugar other than glucose. Its properties are insoluble in water and various organic solvents, soluble in alkali, formic acid solution and urea solution, and once heated to around 60 ° C. and further heated to form a heated gel (high set gel),
Further, after heating to around 60 ° C. and cooling, a cooled gel is formed (a low-set gel). In addition, it forms a film and exhibits a moisturizing effect. Thus, a major characteristic of curdlan is that it differs significantly in its physicochemical properties, especially with temperature and temperature history. That is, the molecular structure of the curdlan is greatly different depending on its temperature history.
【0007】かくして、用いるカードランは、通常市販
されているカードランをそのままでもよく、また、予
め、カードランを水に分散後、加熱し、カードランに特
定のコンフォメーションを取らせたものでもよい。カー
ドランの水への分散に格別の条件や、考慮は特に必要な
いが、水100重量部に対して、カードラン0.1〜5
重量部程度が最も扱いやすい。また、水の量は、組成物
の剤形等を考慮して決める。加熱条件は、40℃以上で
あればよく、好ましくは、60℃以上、さらに好ましく
は、70℃以上の温度で加熱する。加熱上限温度は15
0℃までであれば効果の点では大きな違いはなく、作業
性を考えれば100℃までの範囲で十分である。加熱時
間は、特に限定するものではないが、通常、30秒〜2
0分間の加熱で所望の効果が得られる。本発明の飼料組
成物におけるカードランの含量は、特に限定するもので
はないが、組成物の取り扱いや、効果等の点から、組成
物全量に対して0.05〜5重量%であることが好まし
い。Thus, the curdlan used may be a commercially available curdlan as it is, or may be a curdlan that has been dispersed in water and heated in advance to cause the curdlan to assume a specific conformation. Good. No particular conditions or special considerations are required for dispersing the curdlan in water, but for curdlan 0.1 to 5 per 100 parts by weight of water.
The weight part is the easiest to handle. Further, the amount of water is determined in consideration of the dosage form of the composition and the like. The heating condition may be 40 ° C. or higher, preferably 60 ° C. or higher, more preferably 70 ° C. or higher. Maximum heating temperature is 15
There is no significant difference in the effect up to 0 ° C, and the range up to 100 ° C is sufficient from the viewpoint of workability. The heating time is not particularly limited, but is usually 30 seconds to 2 seconds.
A desired effect can be obtained by heating for 0 minutes. Although the content of curdlan in the feed composition of the present invention is not particularly limited, it may be 0.05 to 5% by weight based on the total amount of the composition from the viewpoint of handling of the composition and effects. preferable.
【0008】本発明の魚類養殖用飼料組成物は、飼料成
分とカードランとを混合して製造される。混合する他の
飼料成分は、特に限定するものではなく、魚類養殖に通
常使用される各種の飼料や、その混合物等いずれでもよ
く、混合方法も特に限定するものではない。また、予
め、自体公知の方法に従って、飼料成分と、カードラン
とを混合した後、粉末、顆粒、ペレット状等の所望の剤
形成形してもよく、あるいは、使用直前に、例えば、通
常使用される公知の魚類養殖用飼料とカードランとを混
合し、要すれば、さらに成形して組成物としてもよい。
例えば、成形前の粉末状態の飼料に、原料の一つとし
て、通常用いられている混合機でカードランを混合すれ
ばよい。その後、必要に応じてエクストルーダー、ペレ
ッターなどで成形し、所望の飼料組成物が得られる。ま
た、加熱したカードランを使用する場合、カードラン分
散液がゲル状ないしペースト状になるので、組成物に配
合するに際しては、例えば、つぶした後、飼料組成物成
形用の水に均一に分散させるなどして、飼料組成物全体
に均一に混合する。[0008] The feed composition for fish culture of the present invention is produced by mixing a feed component with curdlan. The other feed components to be mixed are not particularly limited, and may be any of various feeds usually used for fish farming and mixtures thereof, and the mixing method is not particularly limited. Further, in advance, according to a method known per se, after mixing the feed ingredient and curdlan, a desired dosage form such as powder, granules, pellets or the like may be formed. The known feed for fish culture and curdlan may be mixed and, if necessary, further molded into a composition.
For example, curdlan may be mixed into a powdered feed before molding as one of the raw materials using a commonly used mixer. Then, if necessary, it is molded with an extruder, a pelleter or the like, and a desired feed composition is obtained. In addition, when using a heated curdlan, the curdlan dispersion becomes a gel or paste, so that when it is mixed with the composition, for example, after it is crushed, it is uniformly dispersed in water for forming the feed composition. For example, the mixture is uniformly mixed with the entire feed composition.
【0009】本発明の魚類養殖用飼料組成物は、通常の
飼料組成物と同様な方法で使用でき、組成物の供給量も
特に限定するものではなく、用いた飼料成分の供給量に
応じて与えることができる。本発明の飼料組成物は、養
殖されている各魚種に対応できる。魚類の例としては、
淡水魚のニジマス、コイ、キンギョ、アメリカナマズ、
ウナギ、ティラピア、アユ、ヤマメ、アマゴ、ヒメマ
ス、ブラウンマスなど、海水魚の大西洋サケ、ベニザ
ケ、マスノスケ、サクラマス、ブリ、タイ、クロダイ、
ヒラメ、フグ、シマアジ、カンパチなどがあげられる。The feed composition for aquaculture of fish of the present invention can be used in the same manner as a usual feed composition, and the supply amount of the composition is not particularly limited. Can be given. The feed composition of the present invention can correspond to each type of fish that has been cultured. Examples of fish include
Freshwater fish rainbow trout, carp, goldfish, American catfish,
Saltwater fish such as Atlantic salmon, sockeye salmon, Chinook salmon, cherry salmon, yellowtail, yellowtail, blackfish, eel, tilapia, sweetfish, yamame, amago, brown trout, brown trout, etc.
Flounder, puffer fish, horse mackerel, amberjack and the like.
【0010】また、本発明の組成物は魚類に対して免疫
活性作用を示すことから、対象とする感染症もとくに限
定されるものではない。すなわち、ラブドウィルス、ビ
ルナウィルス、ヘルペスウィルス、イリドウィルスなど
のウィルス病、ノカルディア症、連鎖球菌症、シュード
モナス症、類結節症、鰭赤病、細菌性腎臓病、赤点病、
エロモナス病、せっそう病、ビブリオ病、細菌性鰓病、
レッドマウス病、腸敗血症、パラコロ病、エドワジェラ
症、冷水病、滑走細菌症、カラムナリス病などの細菌
病、水カビ病、ワタカブリ病、真菌性肉芽腫症、イクチ
オホヌス症、ブランキオマイセス症、デルモシスチジウ
ム症、胃拡張症などの真菌病などに対して、魚体そのも
のの防御機能を増進する立場から対応が可能である。さ
らに、カードラン投与区の魚は、対照区の魚と比較し
て、食味の要素中の触覚、視覚(小俣靖著、「美味し
さ」と味覚の科学、日刊工業新聞社)がよいことが認め
られた。すなわち、カードラン投与区の魚は、活力がよ
く、筋肉にはりがあり、健康魚であった。これに対し、
病魚は体色が黒ずみ、体表面粘液が多い傾向にあるが、
カードラン投与区の魚はその様な傾向は認められなかっ
た。さらにまた、カードラン投与区の魚は、対照区の魚
と比較して、肉厚で、料理しやすいことが認められた。[0010] In addition, the composition of the present invention is not particularly limited to the target infectious diseases since it exhibits an immunoreactive effect on fish. That is, rhabdovirus, birnavirus, herpesvirus, iridovirus and other viral diseases, nocardiosis, streptococcal disease, pseudomonassis, nodulopathy, fin red disease, bacterial kidney disease, red spot disease,
Eromonas disease, malignant disease, vibrio disease, bacterial gill disease,
Bacterial diseases such as red mouse disease, intestinal sepsis, parakoloosis, edwajellosis, cold water disease, gliding bacterium disease, and columnaris disease, water mold disease, cotton scab disease, fungal granulomatosis, ichthionosis, blanchiomycosis, dermosis It is possible to respond to fungal diseases such as tidiasis and gastric distension from the standpoint of enhancing the defense function of the fish itself. Furthermore, the fish in the curdlan-administered group had better tactile sensation and visual perception in the taste elements (Yasushi Omata, “Deliciousness and Science of Taste, Nikkan Kogyo Shimbun”) compared to the fish in the control group. Admitted. In other words, the fish in the curdlan-administered group had good vitality, muscle stiffness, and were healthy fish. In contrast,
Diseased fish tend to have darker body color and more mucus on the body surface,
Such tendency was not observed in the fish in the curdlan administration group. Furthermore, it was confirmed that the fish in the curdlan-administered group were thicker and easier to cook than the fish in the control group.
【0011】[0011]
【実施例】つぎに、実施例をあげて本発明をさらに具体
的に説明するが、本発明はこれらに限定されるものでは
ない。実施例1熊本県八代市の養殖場から購入したコイ
(体重約30g)を10尾ずつ、60リットルの水槽に
入れ、水温22〜23℃で1週間予備飼育した後、実験
に供した。なお、予備飼育期間中は市販の養鯉用配合飼
料(日本配合飼料、No.6P)を毎日、飽食するまで与
えた。EXAMPLES Next, the present invention will be described more specifically with reference to examples, but the present invention is not limited to these examples. Example 1 Carp (weight: about 30 g) purchased from a farm in Yatsushiro City, Kumamoto Prefecture was placed in a 60-liter aquarium, each of which was preliminarily reared at a water temperature of 22 to 23 ° C. for one week, and then subjected to an experiment. During the preliminary breeding period, a commercially available mixed feed for carp raising (Japanese mixed feed, No. 6P) was given daily until satiation.
【0012】カードラン配合飼料組成物は、つぎのよう
に製造した。表1に示すごとく、脱イオン水38mlにカ
ードラン(160、310または630mg)を懸濁さ
せ、電子レンジ中で加熱してゲル化させた。各ゲルをミ
キサーにかけて微粒子化した後、各々に粉末化した養鯉
用配合飼料(日本配合飼料、No.6P)62gを加えて
混合し、ペレット状に成形して試験用飼料とした。な
お、試験用飼料(A、BおよびC)は9.7g(コイ1
0尾に対する1日当たりの投与量)ずつに小分けして−
20℃に保存した。The curdlan-containing feed composition was produced as follows. As shown in Table 1, curdlan (160, 310 or 630 mg) was suspended in 38 ml of deionized water and gelled by heating in a microwave oven. Each gel was made into fine particles by using a mixer, and then 62 g of powdered compound feed for carp culture (Japanese compound feed, No. 6P) was added and mixed, and the mixture was formed into pellets to prepare test feed. The test feed (A, B and C) weighed 9.7 g (carp 1).
Daily dose to 0 fish)
Stored at 20 ° C.
【0013】[0013]
【表1】 [Table 1]
【0014】試験用試料の投与はつぎのようにして行っ
た。各試験区のコイに魚体重の3.2%相当量の試験用
飼料(配合飼料に換算すると2%相当量)を1日おきに
5回、朝夕2回に分けて投与した。なお、試験用飼料を
投与しない日および対照区には魚体重の2%相当量の配
合飼料を与えた。1日当たりのカードラン投与量を計算
すると、飼料A区では50mg/kg体重、飼料B区では1
00mg/kg体重、飼料C区では200mg/kg体重とな
る。本実験に用いたエドワルドシエラ・タルダ(Edwar
dsiella tarda) NG8104は、ヒラメ病魚から分離
された菌株である。この菌株の病原性を魚体内通過によ
って高めた後、ハートインヒュージョン寒天培地(日水
製薬)上でそれぞれ36℃、13時間および22℃、1
7時間培養し、滅菌生理食塩水(0.85% NaCl)に
それぞれ2×108CFU/ml、5×107 CFU/ml
となるよう懸濁させた。試験用飼料の最終投与から3日
後にE.tarda菌(2×108CFU/100g体重)を
コイの腹腔内に接種し、7日後の生残率を求めた。生残
率の比較にはFisherの正確確率検定法を用い、P<0.
05のとき有意差があるとみなした。The administration of the test sample was performed as follows. To the carp in each test group, a test feed (equivalent to 2% in terms of combined feed) equivalent to 3.2% of the body weight of the fish was administered five times every other day and twice in the morning and evening. In addition, a compound feed equivalent to 2% of the body weight of the fish was given on the day on which the test feed was not administered and on the control group. The daily curdlan dose was calculated to be 50 mg / kg body weight in feed A section and 1 mg in feed B section.
00 mg / kg body weight and 200 mg / kg body weight in feed C group. Edwardo Sierra Talda used in this experiment
dsiella tarda) NG8104 is a strain isolated from flounder fish. After increasing the pathogenicity of this strain by passing through the fish, it was placed on a heart infusion agar medium (Nissui Pharmaceutical) at 36 ° C., 13 hours and 22 ° C., respectively.
After culturing for 7 hours, 2 × 10 8 CFU / ml and 5 × 10 7 CFU / ml in sterile physiological saline (0.85% NaCl), respectively.
And suspended. Three days after the final administration of the test feed, E. tarda bacteria (2 × 10 8 CFU / 100 g body weight) were inoculated intraperitoneally into carp, and the survival rate 7 days later was determined. For comparison of survival rates, Fisher's exact test was used, and P <0.
At the time of 05, it was considered that there was a significant difference.
【0015】E.tarda菌を用いた攻撃試験の結果を図1
に示す。E.tardaによる攻撃試験では、対照区(飼料D
区)の生残率が20%であったのに対して、50mg/kg
投与区(飼料A区)は60%、100mg/kg投与区(飼
料B区)は70%、200mg/kg投与区(飼料A区)は
40%であった。検定の結果、100mg/kg投与区が対
照区と比較して有意に高かった。なお、このとき、頭腎
食細胞の活性の測定を行った。その方法と結果を以下に
記す。上記の方法でカードラン添加飼料を1日おきに5
回コイに経口投与し、最終投与から3日目に2−メチル
キノリンで麻酔し、背大動脈から脱血後、頭腎組織を摘
出した。頭腎を氷冷RPMI−PC培地(10mMリン
酸塩と0.31%クエン酸ナトリウムを含むRPMI−
1640、pH7.4)5mlを入れたプラスチック製の皿
(直径60mm)に移し、シリコン処理スライドガラス2
枚の間にはさんで頭腎を潰して食細胞を遊離させた。こ
れを試験管に移し、シリコン処理ピペットでピペッティ
ングしてさらに組織をほぐした後、30×gで3分間遠
心して混在する結合組織と細胞の凝集塊を沈降させた。
上層の浮遊細胞をクエン酸ナトリウムを含まないRPM
I培地(RPMI−P)で3回洗浄後、トリパンブルー
排除試験および位相差顕微鏡観察によって生きた食細胞
数を数え、RPMI−Pに1×107cells/mlとなるよ
うに浮遊させた。FIG. 1 shows the results of an attack test using E. tarda bacteria.
Shown in In the challenge test by E. tarda, the control group (feed D)
Area) had a survival rate of 20%, whereas 50 mg / kg
The administration group (feed A section) was 60%, the 100 mg / kg administration section (feed B section) was 70%, and the 200 mg / kg administration section (feed A section) was 40%. As a result of the test, the 100 mg / kg administration group was significantly higher than the control group. At this time, the activity of head kidney phagocytes was measured. The method and results are described below. Use the above method to add curdlan supplemented feed every other day for 5 days.
The carp was orally administered to the carp, and anesthetized with 2-methylquinoline on the third day after the final administration, and blood was removed from the dorsal aorta, and the head kidney tissue was removed. The head kidney was subjected to ice-cold RPMI-PC medium (RPMI-PC medium containing 10 mM phosphate and 0.31% sodium citrate).
1640, pH 7.4) transferred to a plastic dish (60 mm in diameter) containing 5 ml,
The head kidney was crushed between the sheets to release phagocytic cells. This was transferred to a test tube, and the tissue was further loosened by pipetting with a silicon-treated pipette, followed by centrifugation at 30 × g for 3 minutes to sediment aggregated aggregates of connective tissue and cells.
Sodium citrate free RPM
After washing three times with I medium (RPMI-P), the number of living phagocytes was counted by trypan blue exclusion test and phase contrast microscopic observation, and the cells were suspended in RPMI-P at 1 × 10 7 cells / ml.
【0016】一方、パン酵母(Saccharomyces serevis
iae、オリエンタル酵母)500mgを100ml用ビーカ
ーに秤量し、生理食塩水50mlを加えて30分間煮沸し
た。滅菌ガーゼで濾過後、遠心し、沈澱を生理食塩水で
数回洗浄後、10%の牛胎児血清(FBS)を含むPR
MI−P培地に1×108cells/mlとなるよう懸濁させ
た。貧食活性の測定に当っては、頭腎食細胞浮遊液(1
×107cells/ml)100μlと酵母懸濁液(1×108
cells/ml)100μlをシリコン処理試験管中で混合
し、25℃で60分間インキュベートした後、試験管を
氷水につけて貧食を停止させた。この液約50μlをス
ライドグラス上に塗沫して風乾後、ライト染色し、50
0個以上の食細胞を顕微鏡下で観察して食作用指数(P
I)を求めた。On the other hand, baker's yeast (Saccharomyces serevis)
Iae, oriental yeast) (500 mg) was weighed into a 100 ml beaker, and physiological saline (50 ml) was added, followed by boiling for 30 minutes. After filtration with sterile gauze, centrifugation, washing the precipitate several times with physiological saline, PR containing 10% fetal bovine serum (FBS)
The cells were suspended in an MI-P medium at 1 × 10 8 cells / ml. In measuring the phagocytic activity, the suspension of head and kidney phagocytes (1
× 10 7 cells / ml) and yeast suspension (1 × 10 8 cells / ml)
(cells / ml) were mixed in a siliconized test tube and incubated at 25 ° C. for 60 minutes. Then, the test tube was immersed in ice water to stop the poor eating. About 50 μl of this solution was spread on a slide glass, air-dried, and light-stained.
By observing zero or more phagocytes under a microscope, the phagocytosis index (P
I) was determined.
【0017】[0017]
【数1】 (Equation 1)
【0018】PIの平均値の比較にはMann−Whitney
のU検定を用い、P<0.05のとき有意差があるとみ
なした。コイに0、50、100、200mg/kg体重の
カードランを1日おきに5回経口投与して頭腎食細胞の
貧食活性を測定した結果、表2に示すごとく、いずれの
投与区も対照区に比べて有意に高い貧食活性を示した。
中でも50mg/kg区は平均値で対照区の4.9倍の値を
示した。Mann-Whitney is used to compare the average PI values.
Was determined to be significant when P <0.05. As a result of measuring the phagocytic activity of head and kidney phagocytic cells by orally administering curdlan at 0, 50, 100, and 200 mg / kg body weight every other day to carp every other day, as shown in Table 2, all the administration groups showed As compared with the control group, it showed significantly higher poor food activity.
Among them, the 50 mg / kg group showed an average value 4.9 times that of the control group.
【0019】[0019]
【表2】 [Table 2]
【0020】実施例2供試魚のヒラメ(Japanese Flo
under、Pralichthys olivaceus)は、福山大学附属内
海生物資源研究所で孵化後、種苗として飼育したconven
tional fish(平均体重3.5g、平均体長5.2cm、平
均体高2.2cm)を用いた。カードラン配合飼料組成物
はつぎのように製造した。原料としてヒラメ用飼料(丸
紅飼料)1.88kgにカードラン20gを加え、つい
で、フィードオイル(理研ビタミン)0.1kg、水0.3
kgをこの順に加えて全体を混練した。混合機はSHIN
−EIPD10−1を用いた。ついで、不二パウダル製
ディスクペレッターF−5に5mmφのダイを装着して押
し出し、10mmの長さに切断し、成形体を得た。その後
オーブンで乾燥した後スチーミングしたものを飼料とし
た。対照の飼料にはカードランの代わりに、セルロース
(商品名:「KCフロック」、日本製紙)を同量使用し
た。実験は、試験飼料で49日間飼育し、E.tarda F
E1(2×107cell/ml)を26℃の海水に懸濁し、
網篭に入れた魚体を10分間その中に浸漬した。その後
実験槽に戻し、無給餌飼育を行った。感染後毎日午前・
午後に分けて感染状態、延命状況を確かめた。その結
果、図2に示すごとく、感染後の延命は、カードラン投
与区で明らかに高い結果が得られた。なお、生残魚の解
剖所見ではカードラン配合飼料組成物投与区において良
好な症状が認められた。Example 2 Flounder (Japnese Flo) of test fish
under, Pralichthys olivaceus) is a conven bred as a seedling after hatching at the Utsumi Institute of Biological Resources, Fukuyama University
Traditional fish (average weight 3.5 g, average length 5.2 cm, average height 2.2 cm) were used. The curdlan-containing feed composition was produced as follows. As a raw material, 20 g of curdlan was added to 1.88 kg of flatfish feed (Marubeni feed), followed by 0.1 kg of feed oil (RIKEN vitamin) and 0.3 water.
kg were added in this order and the whole was kneaded. The mixing machine is SHIN
-EIPD10-1 was used. Then, a die having a diameter of 5 mm was attached to a disk pelletizer F-5 made by Fuji Paudal, extruded, and cut into a length of 10 mm to obtain a molded body. After that, it was dried in an oven and then steamed to obtain a feed. Instead of curdlan, the same amount of cellulose (trade name: “KC Floc”, Nippon Paper Industries) was used as a control feed. The experiments were maintained on test diets for 49 days. tarda F
E1 (2 × 10 7 cell / ml) is suspended in seawater at 26 ° C.
The fish placed in the net basket was immersed therein for 10 minutes. Thereafter, the animals were returned to the experimental tank and bred without feeding. Every morning after infection
In the afternoon, we checked the infection status and life extension. As a result, as shown in FIG. 2, the life extension after infection was clearly higher in the curdlan-administered group. In the dissection of surviving fish, favorable symptoms were observed in the group to which the curdlan-containing feed composition was administered.
【0021】実施例3実施例2と同様に、中型ヒラメ稚
魚(平均体重60.0g)を用いて中期間(22日間)
の経口給餌後、実施例1と同様にして,E.tarda細菌
(3×107cell/ml)に人為感染させ、延命を検討し
た。図3に示すごとく、感染後19日での延命はカード
ラン配合飼料組成物投与区で明らかに高かった。Example 3 As in Example 2, medium-sized flounder fry (average body weight: 60.0 g) was used for a medium period (22 days).
After oral feeding of E. coli, the same procedure as in Example 1 was repeated. Tarda bacteria (3 × 10 7 cells / ml) were artificially infected and the life extension was examined. As shown in FIG. 3, the life extension on day 19 after infection was clearly higher in the group to which the curdlan-containing feed composition was administered.
【0022】実施例4実施例1と同様にして、大型ヒラ
メを用いて短期間(13日間)の経口給餌後、E.tard
aに人為感染させ、延命を検討した。この時の飼料はつ
ぎのようにして調製した。原料としてヒラメ用飼料(丸
紅飼料)37.6kgにカードラン0.4kgを加え混合し
た。成形機とてアルファライザーα100用い、先端バ
レル温度110℃に設定して成型した。ダイの孔径は8
mmφのものを用いた。ついで、乾燥機中で1時間乾燥
し、飼料とした。対照の飼料にはカードランの代わり
に、セルロース(商品名:「KCフロック」、日本製
紙)を同量使用した。感染後17日間での延命は、図4
に示すごとく、カードラン配合飼料組成物投与区で第2
回試験と同様の結果が得られた。感染後の主要臓器重量
にはほとんど影響を及ぼさなかったが、個々の解剖病理
学的所見ではカードラン配合飼料組成物投与区において
良好な所見が認められた。Example 4 In the same manner as in Example 1, after a short period (13 days) of oral feeding using large flounder, tard
a was artificially infected, and life extension was examined. The feed at this time was prepared as follows. As a raw material, 0.4 kg of curdlan was added to 37.6 kg of flounder feed (Marubeni feed) and mixed. The molding was carried out using an alpha riser α100 as a molding machine, with the tip barrel temperature set at 110 ° C. Die hole diameter is 8
The thing of mmφ was used. Then, it was dried in a dryer for 1 hour to obtain a feed. Instead of curdlan, the same amount of cellulose (trade name: “KC Floc”, Nippon Paper Industries) was used as a control feed. Life extension at 17 days after infection is shown in FIG.
As shown in FIG.
The same results as in the round test were obtained. Although there was little effect on the weight of the main organs after infection, favorable findings were observed in the individual anatomical pathological findings in the group to which the curdlan-containing feed composition was administered.
【0023】[0023]
【発明の効果】以上記載したごとく、本発明によれば、
相対的に安価で、添加効果の優れた養殖魚類用の免疫賦
活剤を配合した新規な魚類養殖用飼料組成物が提供でき
る。As described above, according to the present invention,
It is possible to provide a novel feed composition for fish farming, which is relatively inexpensive and contains an immunostimulant for cultured fish having an excellent addition effect.
【図1】 カードラン配合飼料組成物の経口投与がE.
tarda菌攻撃後のコイの生残率に及ぼす影響を試験した
結果を示すグラフ。FIG. 1. Oral administration of curdlan-containing feed composition was confirmed by E. coli.
7 is a graph showing the results of testing the effect of carp on the survival rate after tarda fungus attack.
【図2】 実施例2における試験結果の感染後日数と生
残率の関係を示すグラフ。FIG. 2 is a graph showing the relationship between the number of days after infection and the survival rate in the test results in Example 2.
【図3】 実施例3における試験結果の感染後日数と生
残率の関係を示すグラフ。FIG. 3 is a graph showing the relationship between the number of days after infection and the survival rate in the test results in Example 3.
【図4】 実施例4における試験結果の感染後日数と生
残率の関係を示すグラフ。FIG. 4 is a graph showing the relationship between the number of days after infection and the survival rate in the test results in Example 4.
フロントページの続き (56)参考文献 特開 平6−172217(JP,A) Yano,T et al:Nipp on Suisan Gakkais i,55,1818−1819(1989) (58)調査した分野(Int.Cl.6,DB名) A23K 1/00 - 1/18 BIOSIS(DIALOG)Continuation of the front page (56) References JP-A-6-172217 (JP, A) Yano, T et al: Nippon Suisan Gakkais i, 55, 1818-1819 (1989) (58) Fields investigated (Int. . 6, DB name) A23K 1/00 - 1/18 BIOSIS (DIALOG )
Claims (3)
する魚類養殖用飼料組成物。1. A feed composition for fish cultivation, comprising curdlan.
0.05〜5重量%である請求項1記載の魚類養殖用飼
料組成物。2. The curdlan content based on the composition is:
The feed composition for fish culture according to claim 1, wherein the amount is 0.05 to 5% by weight.
0℃以上で加熱したカードランである請求項1記載の魚
類養殖用飼料組成物。3. The method according to claim 1, wherein the curd run is used in the presence of water.
The feed composition for fish culture according to claim 1, which is curdlan heated at 0 ° C or higher.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9130875A JP2923263B2 (en) | 1997-05-21 | 1997-05-21 | Feed composition for fish culture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9130875A JP2923263B2 (en) | 1997-05-21 | 1997-05-21 | Feed composition for fish culture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10313794A JPH10313794A (en) | 1998-12-02 |
| JP2923263B2 true JP2923263B2 (en) | 1999-07-26 |
Family
ID=15044744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9130875A Expired - Fee Related JP2923263B2 (en) | 1997-05-21 | 1997-05-21 | Feed composition for fish culture |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2923263B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020094269A (en) * | 2001-06-08 | 2002-12-18 | 주식회사 더멋진 바이오텍 | Feed containing beta-glucan to stimulate the growth of fish |
| CN104206691A (en) * | 2014-09-17 | 2014-12-17 | 中粮营养健康研究院有限公司 | Feed for penaeus vannamei and preparation method of feed for penaeus vannamei |
| CN113749179A (en) * | 2021-09-10 | 2021-12-07 | 南京工业大学 | Application of Kedaran in Preparation of Feed Additives |
| GB202116351D0 (en) * | 2021-11-12 | 2021-12-29 | Givaudan Sa | Feed composition and uses thereof |
| CN117378707A (en) * | 2023-10-08 | 2024-01-12 | 广东海大集团股份有限公司 | A kind of premixed feed that promotes fish growth and improves immunity and its application |
-
1997
- 1997-05-21 JP JP9130875A patent/JP2923263B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| Yano,T et al:Nippon Suisan Gakkaisi,55,1818−1819(1989) |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10313794A (en) | 1998-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Menaga et al. | Effect of in-situ and ex-situ biofloc on immune response of Genetically Improved Farmed Tilapia | |
| Yousefi et al. | The effects of dietary supplement of galactooligosaccharide on innate immunity, immune related genes expression and growth performance in zebrafish (Danio rerio) | |
| Adeshina et al. | Dietary supplementation with Lactobacillus acidophilus enhanced the growth, gut morphometry, antioxidant capacity, and the immune response in juveniles of the common carp, Cyprinus carpio | |
| Lara-Flores | The use of probiotic in aquaculture: an overview | |
| Raa | The use of immune-stimulants in fish and shellfish feeds | |
| Sajeevan et al. | Immunostimulatory effect of a marine yeast Candida sake S165 in Fenneropenaeus indicus | |
| Mohammadian et al. | Modulation of growth performance, gut microflora, non-specific immunity and gene expression of proinflammatory cytokines in shabout (Tor grypus) upon dietary prebiotic supplementation | |
| TW201618676A (en) | Compositions and combinations for use as food supplements for animals | |
| Parmar et al. | Effect of brewer’s yeast on immune response of giant freshwater prawn, Macrobrachium rosenbergii, and its resistance to white muscle disease | |
| Abdulrahman | Comparative effect of probiotic (Saccharomyces cerevisiae), prebiotic (Fructooligosaccharide) and their combination on some blood indices in young common carp (Cyprinus carpio L.): Nasreen M. Abdulrahman and Vian M. Ahmed | |
| Wu et al. | Dietary recombinant human lysozyme improves the growth, intestinal health, immunity and disease resistance of Pacific white shrimp Litopenaeus vannamei | |
| KR20070084398A (en) | Natural bioimmune extract manufacturing process and use of the extract | |
| JPWO2006093267A1 (en) | Fermentation composition having immunomodulatory action | |
| JP2015172019A (en) | Immunostimulator for seafood | |
| Shankar et al. | Effect of nucleotide on growth, immune responses and resistance of Macrobrachium rosenbergii (De Man) to Macrobrachium rosenbergii nodavirus (MrNV) and extra small virus (XSV) and Aeromonas hydrophila infection | |
| JP4052534B2 (en) | Seafood products and feed | |
| Hussain et al. | Lactoferrin in Aquaculture: A Holistic Review of its Health Benefits and Functional Feed Application. | |
| CN113491717B (en) | A sea fungus extract for improving fish immunity and disease resistance, its preparation method and use | |
| JP2923263B2 (en) | Feed composition for fish culture | |
| JP2002012552A (en) | Immune activation-adjusting agent for human and animal, and method for preventing and treating infectious disease, skin disease and cancer of human and animal | |
| Kazuń et al. | Effects of long-term administration of various dietary prebiotic supplements on the growth, immune cell activity and digestive tract histology of juvenile vimba (Vimba vimba) | |
| JP2010077056A (en) | Infectious disease prophylactic | |
| JP2824185B2 (en) | Fish immunostimulants | |
| CN112891360B (en) | New application of deoxyrhapontin | |
| CN112891363B (en) | New Zealand vitexin 2 and new Zealand vitexin 3 application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19990406 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080430 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090430 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100430 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100430 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110430 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110430 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120430 Year of fee payment: 13 |
|
| LAPS | Cancellation because of no payment of annual fees |